
- ICICI Prudential’s net income for the fourth quarter was 3.86 billion rupees, surpassing the estimated 2.54 billion rupees.
- The net premium income for the period was 163.69 billion rupees.
- Other income reported was 525.7 million rupees.
- Yearly results show a 6.4% increase in the value of new business.
- ICICI Prudential shares increased by 2.6%, reaching 567.15 rupees, with 3.74 million shares traded.
- Analyst recommendations include 21 buys, 12 holds, and 1 sell for the company’s stock.
A look at ICICI Prudential Life Insurance Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
ICICI Prudential Life Insurance, a company based in India, offers life insurance services to its customers. The company provides claim processing, electronic insurance accounts, and other related services within the Indian market. Utilizing the Smartkarma Smart Scores, ICICI Prudential Life Insurance has received a moderate overall outlook. With scores of 2 in both Value and Dividend factors, and scores of 3 in Growth, Resilience, and Momentum, the company shows a steady performance in terms of growth potential and market resilience.
In the long-term outlook, ICICI Prudential Life Insurance seems to have a stable footing, with a balanced mix of factors contributing to its overall Smart Scores. While Value and Dividend scores could be improved, the company’s strong points lie in its Growth, Resilience, and Momentum factors. This suggests that ICICI Prudential Life Insurance may have a promising future ahead, backed by its ability to maintain growth momentum and market resilience in the evolving landscape of the life insurance industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars